P

Inventor

BLOUIN MARC

CA12 patents
⚠️ This page may combine multiple inventors who share the name “BLOUIN MARC”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MERCK FROSST CANADA INC

7 patents
US5710170AJan 20, 1998

Tri-aryl ethane derivatives as PDE IV inhibitors

MERCK FROSST CANADA INC108 citations97
US6204275B1Mar 20, 2001

PDE IV inhibiting compounds, compositions and methods of treatment

MERCK FROSST CANADA INC71 citations94
US6200993B1Mar 13, 2001

Heterosubstituted pyridine derivatives as PDE4 inhibitors

MERCK FROSST CANADA INC30 citations92
US6399636B2Jun 4, 2002

Tri-aryl-substituted-ethane PDE4 inhibitors

MERCK FROSST CANADA INC9 citations71
US5334597AAug 2, 1994

Indole carbamates as leukotriene antagonists

MERCK FROSST CANADA INC2 citations62
US5410054AApr 25, 1995

Heteroaryl quinolines as inhibitors of leukotriene biosynthesis

MERCK FROSST CANADA INC4 citations60
US6841564B2Jan 11, 2005

Tri-aryl-substituted-ethane PDE4 inhibitors

MERCK FROSST CANADA INC0 citations50

MERCK SHARP & DOHME

2 patents
US9376418B2Jun 28, 2016

Substituted pyridine spleen tyrosine kinase (SYK) inhibitors

MERCK SHARP & DOHME5 citations71
US9487504B2Nov 8, 2016

Imidazolyl analogs as syk inhibitors

MERCK SHARP & DOHME1 citations50

MERCK FROSST CANADA LTD

1 patent
US7553973B2Jun 30, 2009

Pharmaceutical compounds

MERCK FROSST CANADA LTD3 citations61

BLOUIN MARC

1 patent
US8969394B2Mar 3, 2015

Thiophenecarboxamide derivatives as EP4 receptor ligands

BLOUIN MARC1 citations45

MERCK FORSST CANADA & CO

1 patent
US7439260B2Oct 21, 2008

7-(1,3-thiazol-2-YL)thio-coumarin derivatives and their use as leukotriene biosynthesis inhibitors

MERCK FORSST CANADA & CO0 citations30